colchicine has been researched along with Angor Pectoris in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Angoulvant, D; Berry, C; Bertrand, OF; Blondeau, L; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lavoie, MA; López-Sendón, J; Maggioni, AP; Orfanos, A; Ostadal, P; Pinto, FJ; Provencher, M; Rhainds, D; Roubille, F; Tardif, JC; Waters, DD | 1 |
| Berry, C; Bertrand, OF; Blondeau, L; Bouabdallaoui, N; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lim, P; Lopez-Sendon, J; Maggioni, AP; Morel, O; Orfanos, A; Pinto, FJ; Roubille, F; Samuel, M; Tardif, JC; Waters, DD | 1 |
| Aimo, A; Bayes-Genis, A; Emdin, M; Georgiopoulos, G; Pascual Figal, DA | 1 |
| Alexy, T; Iqbal, A; Mitchell, AJ; Rubinsztain, L; Searles, CD; Shah, AJ; Zafari, AM | 1 |
| KNAPP, HA | 1 |
| Chaldakov, GN | 1 |
| Fleckenstein, L; Lasagna, L; Mazzullo, JM; Mundy, GR; Sundaresan, PR; Weintraub, M | 1 |
1 review(s) available for colchicine and Angor Pectoris
| Article | Year |
|---|---|
Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
Topics: Acute Coronary Syndrome; Angina Pectoris; Colchicine; Coronary Artery Disease; Dose-Response Relationship, Drug; Gout Suppressants; Humans; Myocardial Infarction; Proportional Hazards Models | 2021 |
2 trial(s) available for colchicine and Angor Pectoris
| Article | Year |
|---|---|
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Topics: Aged; Angina Pectoris; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Colchicine; Double-Blind Method; Female; Humans; Incidence; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Proportional Hazards Models; Recurrence; Stroke | 2019 |
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
Topics: Angina Pectoris; Colchicine; Humans; Myocardial Infarction; Stroke; Time-to-Treatment; Treatment Outcome | 2020 |
4 other study(ies) available for colchicine and Angor Pectoris
| Article | Year |
|---|---|
Rheumatoid Arthritis Presenting as Acute Myopericarditis.
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Colchicine; Coronary Angiography; Diagnosis, Differential; Echocardiography; Heart; Humans; Indomethacin; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Pericarditis; Rheumatoid Factor; Troponin | 2016 |
Uricosuric treatment in angina pectoris.
Topics: Angina Pectoris; Colchicine; Gout; Humans; Probenecid | 1963 |
Proposal for clinical trials using anti-inflammatory drugs in the therapy of angina pectoris, myocardial infarction and coronary restenosis after angioplasty and bypass grafting.
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Clinical Trials as Topic; Colchicine; Griseofulvin; Humans; Myocardial Infarction; Recurrence; Sulfasalazine | 1992 |
Current medical practice and the Food and Drug Administration. Some evidence for the existing gap.
Topics: Adult; Aged; Allopurinol; Angina Pectoris; Cephalexin; Child; Colchicine; Diuretics; Drug Labeling; Drug Prescriptions; Drug Therapy; Gout; Humans; Hypertension; Iron; Middle Aged; Physicians; Postoperative Complications; Propranolol; Retrospective Studies; United States; United States Food and Drug Administration; Uric Acid | 1974 |